ABX · Abacus Global Management, Inc. · Insider Trading

The price reported is the weighted average sale price. Shares were sold in multiple transactions at prices ranging from $7.63 to $7.88, inclusive. The transactions reported of this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 18, 2026. The Reporting Person undertakes to provide full transaction details for the transactions set forth in this report to the Commission staff, the Issuer, or a security holder of the Issuer upon request.

The price reported is the weighted average sale price. Shares were sold in multiple transactions at prices ranging from $7.63 to $7.88, inclusive. The transactions reported of this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 18, 2026. The Reporting Person undertakes to provide full transaction details for the transactions set forth in this report to the Commission staff, the Issuer, or a security holder of the Issuer upon request.

The price reported is the weighted average sale price. Shares were sold in multiple transactions at prices ranging from $7.63 to $7.86, inclusive. The transactions reported of this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 18, 2026. The Reporting Person undertakes to provide full transaction details for the transactions set forth in this report to the Commission staff, the Issuer, or a security holder of the Issuer upon request.

The price reported is the weighted average sale price. Shares were sold in multiple transactions at prices ranging from $7.70 to $8.14, inclusive.

The price reported is the weighted average sale price. Shares were sold in multiple transactions at prices ranging from $7.70 to $8.14, inclusive.

The price reported is the weighted average sale price. Shares were sold in multiple transactions at prices ranging from $7.70 to $8.14, inclusive.

The price reported is the weighted average sale price. Shares were sold in multiple transactions at prices ranging from $7.97 to $8.61, inclusive.

The price reported is the weighted average sale price. Shares were sold in multiple transactions at prices ranging from $7.97 to $8.61, inclusive.

The price reported is the weighted average sale price. Shares were sold in multiple transactions at prices ranging from $7.97 to $8.61, inclusive.

The price reported is the weighted average sale price. Shares were sold in multiple transactions at prices ranging from $8.68 to $8.94, inclusive. The transactions reported in footnotes (1), (2), and (3) of this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 18, 2025. The Reporting Person undertakes to provide full transaction details for the transactions set forth in footnotes (1), (2), and (3) to the Commission staff, the Issuer, or a security holder of the Issuer upon request.

The price reported is the weighted average sale price. Shares were sold in multiple transactions at prices ranging from $8.68 to $8.93, inclusive. The transactions reported in footnotes (1), (2), and (3) of this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 18, 2025. The Reporting Person undertakes to provide full transaction details for the transactions set forth in footnotes (1), (2), and (3) to the Commission staff, the Issuer, or a security holder of the Issuer upon request.

The price reported is the weighted average sale price. Shares were sold in multiple transactions at prices ranging from $8.68 to $8.94, inclusive. The transactions reported in footnotes (1), (2), and (3) of this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 18, 2025. The Reporting Person undertakes to provide full transaction details for the transactions set forth in footnotes (1), (2), and (3) to the Commission staff, the Issuer, or a security holder of the Issuer upon request.

The Reporting Person sold shares of Common Stock in open market transactions to satisfy estimated tax obligations. Represents shares of Common Stock sold in open market transactions on August 20, 2026. The price reported in Column 4 is a weighted average price. These sales were executed in multiple transactions at prices ranging from $8.92 to $9.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The Reporting Person sold shares of Common Stock in open market transactions to satisfy estimated tax obligations. The shares were sold in multiple transactions at prices ranging from $8.530 to $9.070, and the price reported in Column 4 represents the weighted average sale price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Represents shares of the Issuer's common stock contributed by the Reporting Person to the Fidelity Exchange Fund (the "Fund") in exchange for an interest in the Fund, pursuant to a contribution arrangement among the Reporting Person and the Fund. The shares were held in escrow pending the contribution and were valued using the Issuer's closing share price on July 31, 2026; the contribution to the Fund was completed on August 3, 2026.

Represents shares of the Issuer's common stock contributed by the Reporting Person to the Fidelity Exchange Fund (the "Fund") in exchange for an interest in the Fund, pursuant to a contribution arrangement among the Reporting Person and the Fund. The shares were held in escrow pending the contribution and were valued using the Issuer's closing share price on July 31, 2026; the contribution to the Fund was completed on August 3, 2026.

Represents shares of the Issuer's common stock contributed by the Reporting Person to the Fidelity Exchange Fund (the "Fund") in exchange for an interest in the Fund, pursuant to a contribution arrangement among the Reporting Person and the Fund. The shares were held in escrow pending the contribution and were valued using the Issuer's closing share price on July 31, 2026; the contribution to the Fund was completed on August 3, 2026.

Represents shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person has elected to satisfy tax withholding obligations through a "withhold to cover" transaction.

Represents shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person has elected to satisfy tax withholding obligations through a "withhold to cover" transaction.

Each performance right represents the contingent right to receive, at settlement, one share of the Issuer's common stock.

On June 3, 2026, Reporting Person was granted the right to receive 1,000,000 shares of the Issuer's common stock if certain Issuer market capitalization or assets under management targets are satisfied during 2026.

Each performance right represents the contingent right to receive, at settlement, one share of the Issuer's common stock.

On June 3, 2026, Reporting Person was granted the right to receive 1,000,000 shares of the Issuer's common stock if certain Issuer market capitalization or assets under management targets are satisfied during 2026.

Each performance right represents the contingent right to receive, at settlement, one share of the Issuer's common stock.

On June 3, 2026, Reporting Person was granted the right to receive 2,000,000 shares of the Issuer's common stock if certain Issuer market capitalization or assets under management targets are satisfied during 2026.

Each performance right represents the contingent right to receive, at settlement, one share of the Issuer's common stock.

On June 3, 2026, Reporting Person was granted the right to receive 1,000,000 shares of the Issuer's common stock if certain Issuer market capitalization or assets under management targets are satisfied during 2026.

Represents shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person has elected to satisfy tax withholding obligations through a "withhold to cover" transaction.

Represents shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person has elected to satisfy tax withholding obligations through a "withhold to cover" transaction.

Represents shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person has elected to satisfy tax withholding obligations through a "withhold to cover" transaction.

Represents shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person has elected to satisfy tax withholding obligations through a "withhold to cover" transaction.

Represents shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person has elected to satisfy tax withholding obligations through a "withhold to cover" transaction.

Reflects Issuer's grant of 730,144 Restricted Stock Units (RSUs) that were made subject to performance-based vesting on May 8, 2025 for which the performance-based criteria have now been satisfied. These RSUs vest one-third (1/3) of the total amount that satisfied the performance-based vesting criteria on each of the first three anniversaries of the grant date.

Reflects Issuer's grant of 357,770 Restricted Stock Units (RSUs) that were made subject to performance-based vesting on May 8, 2025 for which the performance-based criteria have now been satisfied. These RSUs vest one-third (1/3) of the total amount that satisfied the performance-based vesting criteria on each of the first three anniversaries of the grant date.

Reflects Issuer's grant of 211,742 Restricted Stock Units (RSUs) that were made subject to performance-based vesting on May 8, 2025 for which the performance-based criteria have now been satisfied. These RSUs vest one-third (1/3) of the total amount that satisfied the performance-based vesting criteria on each of the first three anniversaries of the grant date.

Reflects Issuer's grant of 211,742 Restricted Stock Units (RSUs) that were made subject to performance-based vesting on May 8, 2025 for which the performance-based criteria have now been satisfied. These RSUs vest one-third (1/3) of the total amount that satisfied the performance-based vesting criteria on each of the first three anniversaries of the grant date.

Reflects Issuer's grant of 211,742 Restricted Stock Units (RSUs) that were made subject to performance-based vesting on May 8, 2025 for which the performance-based criteria have now been satisfied. These RSUs vest one-third (1/3) of the total amount that satisfied the performance-based vesting criteria on each of the first three anniversaries of the grant date.

Includes the sale reported on this Form 4, which represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person has elected to satisfy tax withholding obligations through a "sell to cover" transaction.

Includes the sale reported on this Form 4, which represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person has elected to satisfy tax withholding obligations through a "sell to cover" transaction.

Includes the sale reported on this Form 4, which represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person has elected to satisfy tax withholding obligations through a "sell to cover" transaction.

Includes 8,000 shares of Common Stock that vested on February 13, 2026 (in connection with the Issuer's grant of 24,000 Restricted Stock Units (RSUs) to the Reporting Person on February 13, 2024 with a third of the total amount granted on each of the first three anniversaries of the grant date).

Includes certain time-based RSUs that remain outstanding that will vest and be converted to a like number of the Issuer's Common Stock that were previously reported on Table II, including 81,856 time-based RSUs, granted on April 3, 2025, a third of which will vest on each of March 27, 2026, March 27, 2027 and March 27, 2028, and including RSUs granted to the Reporting Person on February 13, 2024, a third of which vest on each anniversary of the grant, with 8,000 remaining and scheduled to vest on February 13, 2027.

Does not include 3,847,046 shares of Common Stock held by trusts established by the Reporting Person, of which the Reporting Person disclaims beneficial ownership.

Includes 8,000 shares of Common Stock that vested on February 13, 2026 (in connection with the Issuer's grant of 24,000 Restricted Stock Units (RSUs) to the Reporting Person on February 13, 2024 with a third of the total amount granted on each of the first three anniversaries of the grant date).

Includes certain time-based RSUs that remain outstanding that will vest and be converted to a like number of the Issuer's Common Stock that were previously reported on Table II, including 81,856 time-based RSUs, granted on April 3, 2025, a third of which will vest on each of March 27, 2026, March 27, 2027 and March 27, 2028, and including RSUs granted to the Reporting Person on February 13, 2024, a third of which vest on each anniversary of the grant, with 8,000 remaining and scheduled to vest on February 13, 2027.

Includes 8,000 shares of Common Stock that vested on February 13, 2026 (in connection with the Issuer's grant of 24,000 Restricted Stock Units (RSUs) to the Reporting Person on February 13, 2024 with one-third (1/3) of the total amount granted on each of the first three anniversaries of the grant date).

Includes certain time-based RSUs that remain outstanding that will vest and be converted to a like number of the Issuer's common stock that were previously reported on Table II, including 81,856 time-based RSUs, granted on April 3, 2025, a third of which will vest on each of March 27, 2026, March 27, 2027 and March 27, 2028, and including RSUs granted to the Reporting Person on February 13, 2024, a third of which vest on each anniversary of the grant, with 8,000 remaining and scheduled to vest on February 13, 2027.

Includes 8,000 shares of Common Stock that vested on February 13, 2026 (in connection with the Issuer's grant of 24,000 Restricted Stock Units (RSUs) to the Reporting Person on February 13, 2024 with a third of the total amount granted on each of the first three anniversaries of the grant date).

Includes certain time-based RSUs that remain outstanding that will vest and be converted to a like number of the Issuer's Common Stock that were previously reported on Table II, including 81,856 time-based RSUs granted on April 3, 2025, a third of which will vest on each of March 27, 2026, March 27, 2027 and March 27, 2028, and including RSUs granted to the Reporting Person on February 13, 2024, a third of which vest on each anniversary of the grant with 8,000 remaining and scheduled to vest on February 13, 2027.

Does not include 3,847,046 shares of common stock held by trusts established by Reporting Person, of which Reporting Person disclaims beneficial ownership.

Reflects the vesting of 283,333 shares on July 3, 2025, which reflects the vesting of 2/3 of the RSUs granted to the Reporting Person on October 27, 2023, to account for the vesting of 166,667 shares on July 3, 2025, plus the vesting of an additional 116,666 shares from the October 27, 2023 RSU grant following the Issuer's modification of the October 27, 2023 RSU grant terms that, as revised on March 27, 2025, provides for the vesting of one-third of the grant on each of July 3 of 2024, 2025 and 2026.

Includes certain time-based RSUs that remain outstanding that will vest and be converted to a like number of the Issuer's common stock that were previously reported on Table II, including (i) 166,667 time-based RSUs granted on October 27, 2023, and revised on March 27, 2025, providing that, as revised, effective July 3, 2025 one-third of the RSUs are to vest on July 3 of each of 2024, 2025, and 2026 and (ii) 8,000 time-based RSUs granted on February 13, 2024, one third of which will vest on February 13 of each of 2025, 2026, and 2027, (iii) 125,000 time-based RSUs granted on December 13, 2024, one third of which will vest on December 13 of each of 2025, 2026, and 2027, and (ii) 125,000 time-based RSUs granted on April 2, 2025, one third of which will vest on March 27 of each of 2026, 2027, and 2028.

Includes 4,000 shares of Common Stock that vested on February 13, 2025 (in connection with the Issuer grant of 12,000 RSUs to the Reporting Person on February 13, 2024 with one-third (1/3) of the total amount granted vesting on each of the first three anniversaries of the grant date).

Includes 33,000 shares held joint with Reporting Person's spouse.

On 6/4/2025 the Reporting Person (RP) filed a Form 4 that disclosed that the RP acquired 8,000 shares of Common Stock (CS) as the result of a vesting of a Restricted Stock Unit (RSU) award. However, those shares were inadvertently not included in the total number of shares directly held by the RP. Additionally, the Form 4 disclosed that the RP acquired 86,207 shares that are indirectly held through a limited liability company with the RP's spouse. However, these shares were inadvertently added to the RP's total direct holdings, thereby causing the RP's direct holdings to be incorrectly stated. Further, when adding these indirectly held shares to the total shares directly reported, 8 shares were erroneously included. As such, this amendment adds the 8,000 shares to the RP's direct holdings and adds a new row to Table I to disclose the RP's indirect holdings. It also removes 86,215 shares from the RP's direct holdings.

On June 4, 2025, the Reporting Person filed a Form 4 that disclosed that the Reporting Person acquired 86,207 shares that are indirectly held through a limited liability company with the Reporting Person's spouse. However, these shares were inadvertently added to the Reporting Person's total direct holdings, and designated as directly owned in column 6, thereby causing the Reporting Person's direct holdings to be incorrectly stated. As such, this amendment removes the 86,207 shares from the Reporting Person's direct holdings and adds a new row to Table I to disclose the Reporting Person's indirect holdings.